Explore the latest developments in Cell and Gene Therapy with MilliporeSigma.
Join our Tech Forum talk on Monday, May 15th at 5:15pm on Bioprocess development using the VirusExpress(R) 293 AAV platform.
From solving your unique upstream and downstream challenges, to meeting urgent manufacturing timelines, and navigating uncertain regulatory guidelines, our 30+ years of global expertise integrating leading manufacturing technologies with process development, scale-up, product characterization and safety testing is here to help you accelerate your path to cures. Draw on our experience to bring your cell and gene therapies to life.
MilliporeSigma is the U.S. and Canada Life Science business of Merck KgaA, Darmstadt, Germany.